Back
Pasithea Therapeutics Corp. Stock Price Chart
1.5 Million Users. Zero Hype. Still Private.
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
24
KTTA
Pasithea Therapeutics Corp.
Last Price:
$0.74
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and KTTA is experiencing slight selling pressure.
Pasithea Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Sell |
| 20-day SMA: | 0.87 | Sell |
| 50-day SMA: | 0.99 | Sell |
| 200-day SMA: | 0.87 | Sell |
| 8-day EMA: | 0.66 | Buy |
| 20-day EMA: | 0.41 | Buy |
| 50-day EMA: | 0.2 | Buy |
| 200-day EMA: | 0.06 | Buy |
Pasithea Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 26.66 | Sell |
| Chaikin Money Flow: | -226652 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.8 - 1.02) | Sell |
| Bollinger Bands (100): | (0.66 - 1.06) | Sell |
Pasithea Therapeutics Corp. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pasithea Therapeutics Corp. Stock
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 0.73 while KTTA 8-day simple moving average is 0.82, which is a Sell signal.
-
The stock price of KTTA is 0.73 while Pasithea Therapeutics Corp. 20-day SMA is 0.87, which makes it a Sell.
-
Pasithea Therapeutics Corp. 50-day simple moving average is 0.99 while KTTA share price is 0.73, making it a Sell technically.
-
KTTA stock price is 0.73 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.87, creating a Sell signal.
KTTA Technical Analysis vs Fundamental Analysis
Sell
24
Pasithea Therapeutics Corp. (KTTA)
is a Sell
Is Pasithea Therapeutics Corp. a Buy or a Sell?
-
Pasithea Therapeutics Corp. stock is rated a SellThe current Pasithea Therapeutics Corp. [KTTA] share price is $0.73. The Score for KTTA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Pasithea Therapeutics Corp. Stock Info
Market Cap:
5.4M
Price in USD:
0.73
Share Volume:
327.2K
Pasithea Therapeutics Corp. 52-Week Range
52-Week High:
3.79
52-Week Low:
0.28
Sell
24
Pasithea Therapeutics Corp. (KTTA)
is a Sell
Pasithea Therapeutics Corp. Share Price Forecast
-
What is the Pasithea Therapeutics Corp. stock price today?The Pasithea Therapeutics Corp. stock price is 0.73 USD today.
-
Will KTTA stock go up or go down?Pasithea Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pasithea Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pasithea Therapeutics Corp. is overvalued.
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 0.73 while KTTA 8-day exponential moving average is 0.66, which is a Buy signal.
-
The stock price of KTTA is 0.73 while Pasithea Therapeutics Corp. 20-day EMA is 0.41, which makes it a Buy.
-
Pasithea Therapeutics Corp. 50-day exponential moving average is 0.20 while KTTA share price is 0.73, making it a Buy technically.
-
KTTA stock price is 0.73 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of Pasithea Therapeutics Corp.
Is Pasithea Therapeutics Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.82 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Pasithea Therapeutics Corp.
Should I short Pasithea Therapeutics Corp. stock?
-
KTTA Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Pasithea Therapeutics Corp. is a Buy
-
Pasithea Therapeutics Corp. Relative Strength Index (RSI) is 26.66, which suggest Pasithea Therapeutics Corp. is oversold
-
The Bollinger Bands (25) for Pasithea Therapeutics Corp. is (0.8 - 1.02), which suggest Pasithea Therapeutics Corp. is a Sell
-
The Bollinger Bands (100) for Pasithea Therapeutics Corp. is (0.66 - 1.06), which suggest Pasithea Therapeutics Corp. is a Sell
* Pasithea Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.